MediFormatica’s Post

A study published in JAMA Ophthalmology found that vision-related quality of life declined with the presence and severity of diabetic retinopathy (DR). What is vision-related quality of life? It's a measure of how eye conditions impact an individual's daily life, emphasizing the importance of interventions to reduce progression of DR at both early and more advanced stages. Check out this Healio article to learn more: https://hubs.la/Q02wY8Kt0 #DigitalDiagnostics #LumineticsCore #Healthcare #Eyecare

New study demonstrates the potential of using non-mydriatic fundus cameras combined with artificial intelligence software in detecting diabetic retinopathy. Read the full study #OpenAccess here: #Ophthalmology #AI #Diabetes #FOAMed

Comparison of the Outcomes of Anterior Cervical Discectomy and Fusion and Cervical Disc Replacement for Cervical Disc Disease Comparison of Anterior Cervical Discectomy and Fusion (ACDF) versus Cervical Disc Replacement (CDR) for Cervical Disc Disease Study Details: Researchers compared the radiological outcomes and development of heterotopic ossification (HO) in patients who underwent single-segment ACDF and CDR for cervical disc herniation to evaluate their impact on surgical success. Study Duration: January 2020 to June 2022 Study Location: Neurosurgery Department at Bozyaka Education and Research Hospital, Izmir, Turkiye Study Participants: Patients aged 18-70 with radicular neck pain and MRI-confirmed diagnosis of cervical disc disease were included. Patients with osteoporosis were excluded. Results: 56 patients underwent ACDF and 45 underwent CDR. Postoperative disc height increased in both groups. Heterotopic ossification (HO) was more prevalent following CDR during long-term follow-up. Conclusion: ACDF and CDR showed similar improvements in radiological measurements and pain relief. However, HO was more common following CDR during long-term follow-up. Keywords: Cervical disc replacement, Anterior cervical discectomy and fusion, Spinal surgery techniques, Heterotopic ossification. PMID: 38720215 | DOI: 10.29271/jcpsp.2024.05.551 Practical Solutions for Clinics and Healthcare Providers Clinical trials are vital for developing safe and effective treatments, and it’s essential to incorporate their benefits into everyday medical practice. DocSym, our AI-driven platform, consolidates ICD-11 standards, clinical protocols, and research into an easily accessible knowledge base for clinicians. In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally. Using AI, clinics can enhance workflows, improve patient outcomes, and reduce paper routines. Learn more about how we can help at aidevmd.com. https://lnkd.in/gC2zgS-5 #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

Let’s talk about Overactive Bladder (OAB) and neuromodulation therapies. 🧐   OAB is a common condition, affecting 33 million adults in the United States alone. Symptoms of OAB tend to be more severe in females, and the overall prevalence increases with age. The International Continence Society (ICS) defines OAB as a group of lower urinary tract symptoms (LUTS) that includes 'urgency, with or without urge incontinence, usually with increased frequency and nocturia.' Individuals with OAB often experience significant emotional distress and social isolation, which can greatly lower their quality of life. 📉   Currently, neuromodulation treatments for OAB primarily involve tibial nerve stimulation (TNS) and sacral nerve modulation (SNS). Tibial nerve stimulation involves stimulating the tibial nerve, which connects to the sacral nerves. This can be done using various devices and techniques, ranging from percutaneous methods, where a small needle electrode is placed near the ankle, to implantable devices that provide more sustained stimulation. Sacral nerve modulation, on the other hand, involves implanting a device in the lower back to provide continuous stimulation to the sacral nerves. This method can greatly improve symptoms but involves surgery and potential complications.   At InnoCon Medical, we are developing a new patented neuromodulation solution, UCon, targeting the dorsal genital nerve (DGN), a nerve not yet utilized in existing therapies. Several studies have shown that stimulation of the dorsal penile/clitoral nerve (DGN) also benefits patients. Targeting this nerve offers a unique opportunity for on-demand stimulation, which is not possible with current sacral or tibial nerve stimulation techniques. Our UCon system is therefore highly unique & flexible, not only offering continuous and time-limited modes but also a unique urge stimulation mode. This approach has the potential to cater to a wide range of patient needs, making UCon a versatile solution in the field of neuromodulation. 💡   We are currently conducting clinical research to discuss these benefits credibly. For more information and updates, follow us here and/or visit our website: https://lnkd.in/etABgvAh #innovation #neuromodulation #medicaldevices #urology

Central serous chorioretinopathy (CSCR) is the 4th most common retinopathy after AMD, DR, and branch retinal vein occlusion. CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. The biomarkers of CSCR might be difficult to detect and might include: ✅ Subretinal fluid ✅Ellipsoid zone disruption ✅Fibrovascular RPE detachment ✅Double layer sign ✅Serous RPE detachment This is how some of the biomarkers of CSCR might look on the OCT. Altris AI recognizes 70 + biomarkers and retina pathologies including CSCR. If you want to start a free trial of the system in your clinic or optometry center, please contact Mark Braddon.

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗢𝗰𝗰𝗹𝘂𝘀𝗶𝗼𝗻 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Occlusion Removal Devices {Balloon Occlusion Devices, Stent Retrievers, Coil Retrievers, Suction & Aspiration Devices}, Embolization Devices {Embolic Coils, Liquid Embolic Agents, Tubal Occlusion Devices}, Support Devices {Microcatheters, Guidewires}), By Application (Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology), By End User (Hospitals, Diagnostic Centers, & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028. The occlusion devices market pertains to medical devices designed to block or close abnormal blood vessels or other tubular structures in the body, such as arteries, veins, or ducts. These devices are used in various medical procedures to treat conditions like stroke, aneurysms, vascular malformations, and gastrointestinal bleeding. The market for occlusion devices has been witnessing steady growth due to the rising incidence of vascular diseases, technological advancements in device design, and increasing adoption of minimally invasive procedures. 📚 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:👇 https://lnkd.in/dJXtnawe Lepu Medical Orthopedics, Microsulis Medical Limited, Bio-Excel Australia & New Zealand, Taryag Medical ,  Introtek International, Inceptus Medical, Access for Life, Advanced Catheter Therapies, Inc., Aerodentis, CapBuster, Cerenetex, Asius Technologies, LLC, The Brisbane AF Clinic, IVMatters, Nictavi LLC, NIRVA Device, Center for CardioVascular Innovation ,  ThumbRay Technologies, INVISIBLEFAST Europe, Acrostak (Schweiz) AG, Fit Cuffs ApS

https://lnkd.in/gqawgwqM                                                                                              Article title: Atraumatic Acute Limb Ischemia: Clinical Presentation, Classifi cation, Assessment and Management- A Review   Author(s): Nalaka Gunawansa Journal: International Journal of Vascular Surgery and Medicine   Journal ISSN: 2455-5452 Abstract: Acute Limb Ischaemia (ALI) can be a devastating clinical emergency with potentially life or limb threatening consequences. The commonest aetiologies of ALI are traumatic, embolic or thrombotic. While traumatic ALI is fairly obvious in the trauma victim, embolic and thrombotic ALI may mimic other clinical conditions such as neurological disease which may cause delays in diagnosis. Immediate diagnosis, accurate assessment of limb viability and urgent intervention when needed play a crucial role in salvaging the affected limb and preventing a major amputation. Delay in diagnosis and intervention causes irreversible muscle ischaemia leading to eventual limb loss and potential systemic organ dysfunction due to associated lactic acidosis and other toxins. #Embolism #Thrombosis #Ischaemia #Thrombolysis #Amputation #Reperfusion #Angiology #BiochemistryOfBloodFluids #DiseasesOfTheCirculatorySystem #DiseasesOfTheLymphaticSystem #ArterialThrombosisAndEmbolism #Vasculitides #VasospasticDisorders #VenousDiseases #VenousThrombosis #ChronicVenousInsufficiency #VaricoseVeins #LymphaticDiseases #Lymphedema #BloodVesselFormation #HighBloodPressure #BloodAndHypertension #HeartAttack #BloodVesselPathology #Vasoconstriction #VascularImaging #VascularClots #AbdominalAorticAneurysms #Peertechz #PeertechzPublications #BlockageOfBloodVessels #CarotidEndarterectomy #BypassSurgeryForLegArteries #GangreneManagement #RoboticVascularSurgery #AortoIliacDisease #AorticAneurysmSurgery #AorticOcclusionSurgery #EmergencyVascularSurgery #VascularControl #TumorEmbolisation #VaricoseVeinsTreatment #LegUlcersTreatment #VascularDiseaseTreatment #MetabolicDisorders #ArterialOcclusiveDisease #AneurysmalDisease #LymphaticDisorders #ArterialDisease #VenousDisease #PulmonaryDisease #Cardiovascular #Neurovascular #Cerebrovascular #CerebralVascularDisease #VascularDiseaseSymptoms #PeripheralVascularDiseaseSymptoms #PeripheralVascularDiseaseTreatment #CarotidVascularDisease #RenalVascularDisease #HypertensiveVascularDisease #VascularHeartDisease #CollagenVascularDiseaseSymptoms #ArterioscleroticVascularDisease #CardiovascularDiseasePrevention #CirculatoryDiseases #CoronaryVascularDisease

https://lnkd.in/eTiaSHBh Article title: Ocular Safety of Intravitreal Injections of Age-Related Macular Degeneration Treatments in a Prospective Observational Cohort Study in Europe   Author(s): Kui Huang*; Marla B Sultan; Duo Zhou; Charles S Tressler; Jingping Mo   Journal: Journal of Clinical Research and Ophthalmology   Journal ISSN: 2455-1414 Abstract: Purpose: Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (IVT) injections for age-related macular degeneration (AMD) treatments in Europe. Methods: Ophthalmologists prospectively followed patients, who received IVT injection treatment for AMD including Macugen®, Lucentis®, and Avastin® at ophthalmic clinical centers in Europe, and determined outcomes of interest as clinically appropriate up to two years. Main outcomesincluded endophthalmitis, retinal detachment, vitreous hemorrhage, retinal tear, traumatic cataract, and increased intraocular pressure (IOP). #AgeRelatedMacularDegeneration #IntravitrealInjection #Endophthalmitis #IncreasedIntraocularPressure #OphthalmologySubspecialties #Optometry #VisualScience #PharmacologyInEyeDiseases #BasicSciences #PrimaryEyeCare #SecondaryEyeCare #PatientSafety #QualityImprovements #NeuroOphthalmology #MedicalEyeCare #SurgicalEyeCare #GlaucomaFilteringProcedure #OcularDrugDesign #ClinicalPsychophysics #DiabeticRetinopathy #CataractSurgery #RefractiveSurgery #PVRStudies #LowVision #PterygiaStudies #PupilLightReflex #Peertechz #PeertechzPublications #SecondaryCataractStudies #RetinalDiseases #RetinalSurgery #SubstancePStudies #Cornea #ExternalEyeDisease #DefensinsForCorneaTransplants #CraniofacialClinic #OptometryClinic #OphthalmicGeneticsClinic #NeuroOphthalmologyClinic #Oculoplastics #TearingDisordersClinic #PediatricRetinaClinic #CornealNeovascularization #ImmunologicalMechanisms #MolecularMechanisms #LaserTherapyInOphthalmology #ImagingInOphthalmology #OcularImmunology #VisionAndOphthalmology #NeuroOphthalmology